<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC12098553</article-id><article-id pub-id-type="doi">10.3389/fmicb.2025.1546662</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Genomic insights into <italic>bla</italic><sub>AFM</sub>-positive carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> in China</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Huimin</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/investigation/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chuanjun</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role content-type="https://credit.niso.org/contributor-roles/methodology/"/><role content-type="https://credit.niso.org/contributor-roles/software/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Buhui</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/2645325/overview"/><role content-type="https://credit.niso.org/contributor-roles/data-curation/"/><role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/><role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Yan</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/795182/overview"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/visualization/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Qin</surname><given-names>Shangshang</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xlink:href="https://loop.frontiersin.org/people/935475/overview"/><role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/><role content-type="https://credit.niso.org/contributor-roles/project-administration/"/><role content-type="https://credit.niso.org/contributor-roles/resources/"/><role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Pharmacy, Henan Provincial People's Hospital</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>XNA Platform, School of Pharmaceutical Sciences, Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, Zhengzhou University</institution>, <addr-line>Zhengzhou</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by" id="fn0002"><p>Edited by: Shaolin Wang, China Agricultural University, China</p></fn><fn fn-type="edited-by" id="fn0003"><p>Reviewed by: Okon Okwong Kenneth, Federal University, Wukari, Nigeria</p><p>Mahmuda Yasmin, University of Dhaka, Bangladesh</p><p>Muzafar Ahmad Rather, University of Minnesota Twin Cities, United States</p><p>Narjess Bostanghadiri, Tehran University of Medical Sciences, Iran</p></fn><corresp id="c001">*Correspondence: Yan Li, <email>yan_li18@163.com</email>; Shangshang Qin, <email>qinshangshang@126.com</email></corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><elocation-id>1546662</elocation-id><history><date date-type="received"><day>17</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>28</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2025 Lu, Zhang, Zhao, Li and Qin.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Lu, Zhang, Zhao, Li and Qin</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> (CRPA) poses a global threat; however, the epidemiological characteristics and clinical significance of <italic>bla</italic><sub>AFM</sub>-positive CRPA strains in China remain unclear. In this study, continuous surveillance was conducted from 2018 to 2022 in a hospital in Henan Province, China, and the genomic characteristics of <italic>bla</italic><sub>AFM</sub>-positive CRPA were elucidated. We characterised the genetic features of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates by antimicrobial susceptibility testing, conjugation assays, whole-genome sequencing, large-scale comparative genomics, and bioinformatic analyses. Among 628 CRPA isolates, one <italic>bla</italic><sub>AFM</sub>-positive multidrug-resistant (MDR) strain, PA19-3158 (ST1123), was identified, with the <italic>bla</italic><sub>AFM-1</sub> gene located on a novel 518,222&#x0202f;bp megaplasmid. Additionally, big data analysis revealed the genomic characteristics of <italic>bla</italic><sub>AFM</sub>-positive CRPA across China. A total of three different <italic>bla</italic><sub>AFM</sub> gene variants were identified among these isolates, namely <italic>bla</italic><sub>AFM-1</sub> (44.12%), <italic>bla</italic><sub>AFM-2</sub> (52.94%), and <italic>bla</italic><sub>AFM-4</sub> (2.94%). Our findings identified ST463 as the dominant clone among <italic>bla</italic><sub>AFM</sub>-positive CRPA in different regions of China, with some <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates from these regions exhibiting high genetic similarity. Notably, all <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates carried multiple antibiotic resistance genes (ARGs), with approximately 38% co-harboring the carbapenem-resistant gene <italic>bla</italic><sub>KPC-2</sub> and approximately 47% co-harboring the tigecycline-resistant gene <italic>tmexCD-toprJ</italic>. Correlation analysis underscored the significant role of mobile genetic elements in facilitating <italic>bla</italic><sub>AFM</sub> gene transfer. These results highlight the critical need for continuous surveillance of <italic>bla</italic><sub>AFM</sub>-positive CRPA in clinical settings to mitigate potential risks.</p></abstract><kwd-group><kwd>patients</kwd><kwd>carbapenem resistance</kwd><kwd><italic>Pseudomonas aeruginosa</italic></kwd><kwd>
<italic>bla</italic>
<sub>AFM</sub>
</kwd><kwd>genomics</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by National Natural Science Foundation of China (U20041257), Training Plan for Young Backbone Teachers in Colleges and Universities in Henan (2021GGJS016), Key project of Natural Science Foundation of Henan province (252300421272).</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="0"/><equation-count count="0"/><ref-count count="34"/><page-count count="7"/><word-count count="4862"/></counts><custom-meta-group><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Antimicrobials, Resistance and Chemotherapy</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> (CRPA) exhibits extensive drug resistance, poses significant challenges in clinical treatment, and is associated with high mortality rates in infected patients (<xref rid="ref34" ref-type="bibr">Zhu et al., 2023</xref>; <xref rid="ref23" ref-type="bibr">Saravanan et al., 2023</xref>). As such, CRPA has been classified as a &#x0201c;critical priority&#x0201d; pathogen for antibiotic development by the World Health Organization (WHO). The resistance of <italic>P. aeruginosa</italic> to carbapenem antibiotics is primarily mediated by several mechanisms: overexpression of the MexAB-OprM efflux pump, hyperproduction of AmpC &#x003b2;-lactamase, inactivation of OprD porins, and production of carbapenemases (<xref rid="ref8" ref-type="bibr">Gray et al., 2023</xref>; <xref rid="ref19" ref-type="bibr">Livermore, 2002</xref>). Although carbapenemase-producing <italic>P. aeruginosa</italic> constitutes a smaller proportion of CRPA isolates, this proportion has been steadily increasing in recent years (<xref rid="ref22" ref-type="bibr">Reyes et al., 2023</xref>). Among these carbapenemases, metallo-&#x003b2;-lactamases (MBLs) are the most prevalent in CRPA (<xref rid="ref28" ref-type="bibr">Yoon and Jeong, 2021</xref>). The treatment of infections caused by MBL-producing CRPA is particularly challenging, as MBLs confer resistance to most &#x003b2;-lactam antibiotics (<xref rid="ref11" ref-type="bibr">Jean et al., 2019</xref>).</p><p>Historically, NDM was considered the sole member of the subclass B1b MBL. However, in 2018, a novel subclass B1b MBL, <italic>Alcaligenes faecalis</italic> metallo-&#x003b2;-lactamase-1 (AFM-1), was first identified in <italic>Acinetobacter faecalis</italic> isolates in China (<xref rid="ref18" ref-type="bibr">Li et al., 2022</xref>). Since then, AFM-1 has been detected in various bacterial species, including <italic>P. aeruginosa</italic>, <italic>P. putida</italic>, and <italic>Bordetella trematum</italic> (<xref rid="ref18" ref-type="bibr">Li et al., 2022</xref>; <xref rid="ref30" ref-type="bibr">Zhang et al., 2021</xref>). Furthermore, as AFM-1 continues to evolve, multiple variants such as AFM-2, AFM-3, and AFM-4 have been identified in <italic>P. aeruginosa</italic> (<xref rid="ref5" ref-type="bibr">Chen et al., 2022</xref>). However, despite its emergence, reports on bacteria producing this newly discovered MBL remain scarce, and comprehensive studies on AFM-producing pathogens are still lacking.</p><p>To further enhance our understanding of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates, this study conducted a five-year surveillance of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates from hospitals in Henan Province, China, systematically analyzing their characteristics. Additionally, through large-scale data analysis, the genomic features of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates in China were further elucidated.</p></sec><sec sec-type="methods" id="sec2"><title>Methods</title><sec id="sec3"><title>Characterization of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates in clinical settings</title><p>To investigate the presence of <italic>bla</italic><sub>AFM</sub>-positive CRPA among hospitalized patients, continuous surveillance was conducted from 2018 to 2022 in a hospital in Henan Province, China, with over 10,000 beds. The presence of the <italic>bla</italic><sub>AFM</sub> gene was confirmed via PCR, and <italic>bla</italic><sub>AFM</sub>-positive isolates were subjected to further analysis. This study was approved by the Ethics Committee of Zhengzhou University.</p></sec><sec id="sec4"><title>Antimicrobial susceptibility testing of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates</title><p>Minimal inhibitory concentrations (MICs) were determined using the broth microdilution technique, and <italic>E. coli</italic> ATCC 25922 was used as the quality control. The panel of antibiotics tested included meropenem, gentamicin, ciprofloxacin, amikacin, aztreonam, colistin, ceftazidime, piperacillin/tazobactam, fosfomycin, ceftazidime/avibactam, and aztreonam/avibactam. Resistance breakpoints were interpreted according to EUCAST v.14.0 criteria for tigecycline and CLSI guidelines for the remaining antibiotics (<xref rid="ref20" ref-type="bibr">Marchaim et al., 2014</xref>; <xref rid="ref6" ref-type="bibr">CLSI, 2018</xref>).</p></sec><sec id="sec5"><title>Conjugation experiments</title><p>To assess the transferability of the <italic>bla</italic><sub>AFM</sub>-positive plasmid, a conjugation assay was performed using rifampicin-resistant <italic>Escherichia coli</italic> EC600 and hygromycin-resistant <italic>Klebsiella pneumoniae</italic> YZ6 as recipients. Donor and recipient cultures were mixed at a 1:4 ratio and incubated on LB agar plates at 37&#x000b0;C overnight. Transconjugants were selected on LB agar plates supplemented with meropenem (2&#x0202f;mg/L) and rifampin (300&#x0202f;mg/L) or meropenem (2&#x0202f;mg/L) and hygromycin (200&#x0202f;mg/L). PCR was subsequently employed to confirm the presence of <italic>bla</italic><sub>AFM</sub> in the transconjugants.</p></sec><sec id="sec6"><title>Whole-genome sequencing and genome assembly</title><p>To characterize the genetic features of the identified <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates, genomic DNA was extracted using the FastPure bacterial DNA isolation mini kit and quantified with a Qubit 4 Fluorometer. Whole-genome sequencing (WGS) was performed on the Illumina HiSeq 2500 platform with 2&#x0202f;&#x000d7;&#x0202f;150&#x0202f;bp paired-end libraries. <italic>De novo</italic> genome assembly was carried out using SPAdes v.3.14.0 (<xref rid="ref2" ref-type="bibr">Bankevich et al., 2012</xref>). Additionally, <italic>bla</italic><sub>AFM</sub>-positive plasmids were extracted using the Qiagen Plasmid Midi Kit and subjected to Nanopore sequencing. The plasmid sequences were assembled using Unicycler v.0.4.8 (<xref rid="ref26" ref-type="bibr">Wick et al., 2017</xref>). Genome annotation was performed with Prokka v.1.11 (<xref rid="ref24" ref-type="bibr">Seemann, 2014</xref>).</p></sec><sec id="sec7"><title>Screening of <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates in retrospective data from China</title><p>All <italic>P. aeruginosa</italic> genome sequences available in the National Center for Biotechnology Information (NCBI) genome database as of 2 August 2024 were retrieved (<xref rid="ref16" ref-type="bibr">Li et al., 2024</xref>). Subsequently, <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates originating from China were selected for further analysis. Basic information regarding the <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates, including the region, year of isolation, and accession number, was organized into an Excel spreadsheet for downstream analysis.</p></sec><sec id="sec8"><title>Bioinformatics analysis</title><p>ARGs and plasmid replicons were identified using online tools with default parameters (threshold value: 80% identity and coverage) (<xref rid="ref3" ref-type="bibr">Bortolaia et al., 2020</xref>; <xref rid="ref4" ref-type="bibr">Carattoli and Hasman, 2020</xref>). Virulence genes were annotated using the Virulence Factor Database (VFDB) (<xref rid="ref12" ref-type="bibr">Kleinheinz et al., 2014</xref>). Multi-locus sequence typing (MLST) of the isolates was determined using the mlst tool. SNPs in the genomes of <italic>bla</italic><sub>AFM</sub>-positive CRPAs were detected using snp-dists v.0.7.0.<xref rid="fn0001" ref-type="fn"><sup>1</sup></xref> Phylogenetic trees were constructed using Roary and FastTree based on core single-nucleotide polymorphism (SNP) alignments and further refined with iTOL (<xref rid="ref21" ref-type="bibr">Price et al., 2009</xref>; <xref rid="ref14" ref-type="bibr">Letunic and Bork, 2021</xref>). Plasmid comparison maps were generated using BRIG v.0.95 and Easyfig v.2.2.3 (<xref rid="ref1" ref-type="bibr">Alikhan et al., 2011</xref>; <xref rid="ref25" ref-type="bibr">Sullivan et al., 2011</xref>).</p></sec><sec id="sec9"><title>Statistical analysis</title><p>Statistical analyses and visualizations were conducted using R v4.2.2 (R Foundation for Statistical Computing, Vienna, Austria). Spearman correlation analysis was employed to assess relationships among ARGs, insertion sequences, virulence factors, and plasmid replicons. Clinical data were organized using Microsoft Excel 2013.</p></sec><sec sec-type="data-availability" id="sec10"><title>Data availability</title><p>Genome sequence data reported in this study have been deposited in the National Center for Biotechnology Information under the accession number NZ_CP140112.1 (pAFM-PA19-3158). All study data are included in the article and/or supporting information.</p></sec></sec><sec sec-type="results" id="sec11"><title>Results</title><sec id="sec12"><title>Overview of CRPA isolates</title><p>In this study, a single <italic>bla</italic><sub>AFM-1</sub>-positive CRPA strain, designated PA19-3158, was isolated from a hospital in Henan Province, China. This strain was isolated from the blood sample of a 29-year-old male patient in the ICU. MLST analysis revealed that PA19-3158 belongs to ST1123. MIC testing demonstrated resistance to carbapenems as well as aztreonam, ceftazidime, piperacillin/tazobactam, ceftazidime/avibactam, and aztreonam/avibactam, while retaining susceptibility to ciprofloxacin and colistin (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S1</xref>). Additionally, conjugation experiments indicated that the <italic>bla</italic><sub>AFM-1</sub> gene in PA19-3158 was non-transferable to <italic>E. coli</italic> EC600 and <italic>K. pneumoniae</italic> YZ6.</p></sec><sec id="sec13"><title>Characterization of <italic>bla</italic><sub>AFM</sub>-positive plasmids</title><p>To investigate the characteristics of <italic>bla</italic><sub>AFM</sub>-positive plasmids, the plasmids carrying <italic>bla</italic><sub>AFM-1</sub> from PA19-3158 were extracted and subjected to long-read sequencing using the Nanopore platform. Through the combined analysis of short-read and long-read sequencing data, we identified that the <italic>bla</italic><sub>AFM-1</sub> gene is located on a 518,222 bp megaplasmid, with an average GC content of 56.5% and 647 predicted open reading frames (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Interestingly, plasmid typing revealed that this plasmid does not belong to any known replicon type. The plasmid harbors a wide array of resistance genes, including &#x003b2;-lactam resistance genes (<italic>bla</italic><sub>AFM-1</sub>, <italic>bla</italic><sub>OXA-246</sub>, and <italic>bla</italic><sub>CARB-4</sub>), sulfonamide resistance gene (<italic>sul1</italic>), quinolone resistance gene (<italic>qnrVC1</italic>), aminoglycoside resistance genes (<italic>aac(6&#x02032;)-II</italic> and <italic>ant(2&#x02033;)</italic>), trimethoprim resistance gene (<italic>dfrA27</italic>), chloramphenicol resistance genes (<italic>catB11</italic> and <italic>cmlA8</italic>), rifampin resistance gene (<italic>arr-3</italic>), macrolide resistance genes (<italic>msr</italic>(E), <italic>mph</italic>(E), and <italic>mph</italic>(F)), and bleomycin resistance gene (<italic>ble</italic><sub>MBL</sub>).</p><fig position="float" id="fig1"><label>Figure 1</label><caption><p>Circular comparison between <italic>bla</italic><sub>AFM</sub>-bearing plasmids found in this study and the NCBI database. The <italic>bla</italic><sub>AFM</sub>-bearing plasmid pAFM-PA19-3158 was used as the reference in the outermost ring.</p></caption><graphic xlink:href="fmicb-16-1546662-g001" position="float"/></fig><p>BLAST analysis revealed that no plasmids identical to the <italic>bla</italic><sub>AFM-1</sub>-positive plasmid (pAFM-PA19-3158) were found in the NCBI database. However, the plasmids pOZ176 (74% coverage, 99.95% identity) and pWTJH17 (79% coverage, 99.99% identity) exhibited the highest similarity to pAFM-PA19-3158. Both of these plasmids were derived from human-associated <italic>P. aeruginosa</italic>. Compared with the other two plasmids, plasmid pAFM-PA19-3158 carries additional resistance genes (<italic>ant(2&#x02033;)-Ia</italic> and <italic>mph</italic>(F)), suggesting its capacity to continuously acquire resistance determinants and evolve. This poses a further challenge to clinical treatment options by limiting the effectiveness of available antibiotics.</p></sec><sec id="sec14"><title>Phylogenetic evolution of <italic>bla</italic><sub>AFM</sub>-positive genomics in the NCBI database from China</title><p>To further investigate the genomic epidemiological distribution of <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates in China, we retrieved all <italic>P. aeruginosa</italic> genome data from the NCBI database and selected <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates of Chinese origin for further analysis in combination with data from this study (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S2</xref>). A total of 33 eligible isolates were identified from the database. Except for two isolates with unknown sources, the remaining isolates were all derived from human samples. These isolates were distributed across five different regions of China, with the earliest detected in 2017. The <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates have been consistently reported between 2017 and 2023, indicating their persistent presence in clinical settings over time.</p><p>To investigate the evolutionary relationships of <italic>bla</italic><sub>AFM</sub>-positive CRPA in China, we constructed a phylogenetic tree combining <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates from this study with those retrieved from the NCBI database (<xref rid="fig2" ref-type="fig">Figure 2</xref>). We observed a high genetic similarity (SNP number &#x0003c; 100) among <italic>bla</italic><sub>AFM-1</sub>-positive strains from different regions, indicating a potential risk of clonal transmission (<xref rid="SM1" ref-type="supplementary-material">Supplementary Table S3</xref>). Additionally, the <italic>bla</italic><sub>AFM</sub> genes in these isolates were predominantly <italic>bla</italic><sub>AFM-1</sub> (<italic>n</italic>&#x0202f;=&#x0202f;15) and <italic>bla</italic><sub>AFM-2</sub> (<italic>n</italic>&#x0202f;=&#x0202f;18), with only one strain carrying <italic>bla</italic><sub>AFM-4</sub>. MLST analysis classified these isolates into eight known STs, with ST463 being the most prevalent (<italic>n</italic>&#x0202f;=&#x0202f;14), followed by ST275 (<italic>n</italic>&#x0202f;=&#x0202f;8). Notably, <italic>bla</italic><sub>AFM</sub>-positive ST463 strains were detected in all years except 2017 and 2023, suggesting its sustained presence in clinical settings over time.</p><fig position="float" id="fig2"><label>Figure 2</label><caption><p>Phylogenetic tree of 34 <italic>bla</italic><sub>AFM</sub>-positive CRPA strains from this study and the NCBI database. Resistance genes are indicated by squares: solid square indicates positive; hollow square indicates negative.</p></caption><graphic xlink:href="fmicb-16-1546662-g002" position="float"/></fig></sec><sec id="sec15"><title>Distribution of ARGs in <italic>bla</italic><sub>AFM</sub>-positive strains</title><p>Resistance gene analysis revealed that <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates harbored a wide range of ARGs. Across different years, 10 shared ARGs were identified among the isolates, with those from 2021 carrying the highest number of unique ARGs (<italic>n</italic>&#x0202f;=&#x0202f;9), followed by 2019 (<italic>n</italic>&#x0202f;=&#x0202f;5). In addition to the <italic>bla</italic><sub>AFM</sub> gene, other carbapenem resistance genes such as <italic>bla</italic><sub>IMP-45</sub> (<italic>n</italic>&#x0202f;=&#x0202f;5) and <italic>bla</italic><sub>KPC-2</sub> (<italic>n</italic>&#x0202f;=&#x0202f;13) were also detected in several isolates. Notably, ARGs including <italic>aph(3&#x02032;)-IIb</italic> (34/34), <italic>fosA</italic> (34/34), <italic>sul1</italic> (34/34), <italic>tmexD</italic> (34/34), <italic>ble</italic><sub>MBL</sub> (34/34), <italic>catB7</italic> (34/34), and <italic>bla</italic><sub>PDC-374</sub> (32/34) were identified in the majority of isolates. In contrast, genes such as <italic>bla</italic><sub>TEM-1</sub>, <italic>bla</italic><sub>OXA-494</sub>, and <italic>bla</italic><sub>PDC-172</sub> were detected in only a single isolate. This highlights both the conserved and variable resistance profiles of <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> across different years.</p></sec><sec id="sec16"><title>Correlation analysis of ARGs, virulence factors, insertion sequences and plasmid replicons</title><p>In total, 68 ARGs, 3 plasmid replicons, 67 insertion sequences, and 333 virulence factors were identified in the <italic>bla</italic><sub>AFM</sub>-positive <italic>P. aeruginosa</italic> isolates. To investigate the relationship between ARGs, insertion sequences, plasmid replicons, and virulence factors in these isolates, a correlation analysis was performed (<xref rid="fig3" ref-type="fig">Figures 3A</xref>&#x02013;<xref rid="fig3" ref-type="fig">C</xref>). The linear association analysis indicated that the number of ARGs in <italic>bla</italic><sub>AFM</sub>-positive isolates showed a positive correlation with insertion sequences (rSpearman&#x0202f;=&#x0202f;0.31, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.001). However, no significant correlations were observed with plasmid replicons or virulence factors (|rSpearman|&#x0202f;&#x0003c;&#x0202f;0.3).</p><fig position="float" id="fig3"><label>Figure 3</label><caption><p>Correlation between ARGs, plasmid replicons, insertion sequences and Virulence genes. <bold>(A&#x02013;C)</bold> The correlation of counts of ARGs, plasmid replicons, insertion sequences and VFs detected from genomes of CRPA. <bold>(D)</bold> The correlation of <italic>bla</italic><sub>AFM</sub> with other ARGs and insertion sequences. The nodes represent ARGs or insertion sequences. Connections between nodes indicate that they are related. Bluer colors and thicker lines represent stronger positive correlations. The yellower the color and the thicker the lines represent the stronger the negative correlation. All associated genes in the figure had <italic>p</italic> values less than 0.05.</p></caption><graphic xlink:href="fmicb-16-1546662-g003" position="float"/></fig><p>To further examine the relationship between ARGs and insertion sequences, a network graph was constructed (<xref rid="fig3" ref-type="fig">Figure 3D</xref>). The results revealed that <italic>bla</italic><sub>AFM-2</sub> exhibited strong positive correlations with IS<italic>Cfr1</italic>, <italic>ant(2&#x02033;)-Ia</italic>, and <italic>aac(6&#x02032;)-IIa</italic> (<italic>R</italic>&#x0202f;&#x0003e;&#x0202f;0.8, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05). Similarly, <italic>bla</italic><sub>AFM-1</sub> was positively correlated with <italic>aph(3&#x02033;)-Ib</italic>, IS<italic>5564</italic>, and <italic>aac(6&#x02032;)-Ib-G</italic> (<italic>R</italic>&#x0202f;&#x0003e;&#x0202f;0.5, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05). In contrast, no ARGs showed significant correlations with <italic>bla</italic><sub>AFM-4</sub>, although it displayed positive correlations with insertion sequences IS<italic>Pa1635</italic>, IS<italic>Ppu22</italic>, and IS<italic>Psp7</italic> (<italic>R</italic>&#x0202f;&#x0003e;&#x0202f;0.5, <italic>p</italic>&#x0202f;&#x0003c;&#x0202f;0.05).</p></sec></sec><sec sec-type="discussion" id="sec17"><title>Discussion</title><p>In 2021, Lin et al. identified AFM-1 (<italic>Alcaligenes faecalis</italic> metallo-&#x003b2;-lactamase-1), a novel metallo-&#x003b2;-lactamase (MBL), as a new variant of NDM-1 through molecular and functional characterization (<xref rid="ref30" ref-type="bibr">Zhang et al., 2021</xref>). Phylogenetic analysis demonstrated that AFM-1 shares 86% amino acid sequence homology with NDM-1. However, due to the low detection rate of the <italic>bla</italic><sub>AFM</sub> gene in <italic>P. aeruginosa</italic>, systematic studies on <italic>bla</italic><sub>AFM</sub>-positive strains remain scarce (<xref rid="ref5" ref-type="bibr">Chen et al., 2022</xref>; <xref rid="ref32" ref-type="bibr">Zhang et al., 2023</xref>). To address this knowledge gap, this study conducted long-term surveillance of <italic>bla</italic><sub>AFM</sub>-positive strains in hospitals in Henan Province, China. Using genomic approaches, we characterized the features of a <italic>bla</italic><sub>AFM</sub>-positive strain isolated from Henan. Besides, we further analyzed the genomic characteristics of all <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates reported in China.</p><p>Previous studies have indicated that <italic>bla</italic><sub>KPC</sub>-producing CRPA accounts for approximately 40% of clinical CRPA infections in certain regions, with ST463 identified as the predominant <italic>bla</italic><sub>KPC</sub>-positive clone (<xref rid="ref10" ref-type="bibr">Hu et al., 2021</xref>). Importantly, ST463 has emerged as a major CRPA lineage responsible for bloodstream infections and is associated with significantly higher mortality rates compared to non-ST463 CRPA infections (<xref rid="ref29" ref-type="bibr">Zhang et al., 2023</xref>). Our findings revealed that ST463 is the dominant clone among <italic>bla</italic><sub>AFM</sub>-positive CRPA in China, with approximately 38% of these isolates co-harboring the <italic>bla</italic><sub>KPC-2</sub> gene. The coexistence of both enzymes may confer resistance to nearly all &#x003b2;-lactam antibiotics severely limiting treatment options, increasing healthcare costs, and elevating patient mortality rates. The potential spread of these multidrug-resistant and highly pathogenic strains poses a significant risk of clinical treatment failure, underscoring the urgent need for continuous surveillance of ST463 <italic>bla</italic><sub>AFM</sub>-positive CRPA strains.</p><p>The <italic>bla</italic><sub>AFM</sub> gene has been detected in various bacterial genera, but it is relatively rare in <italic>P. aeruginosa</italic> (<xref rid="ref18" ref-type="bibr">Li et al., 2022</xref>; <xref rid="ref7" ref-type="bibr">Fang et al., 2023</xref>). However, due to its ability to spread via plasmids and other mobile genetic elements, it warrants close attention (<xref rid="ref5" ref-type="bibr">Chen et al., 2022</xref>; <xref rid="ref33" ref-type="bibr">Zhou et al., 2023</xref>). This study identified a novel, large plasmid carrying the <italic>bla</italic><sub>AFM</sub> gene, which harbors a greater number of resistance genes compared to other similar plasmids. This suggests that plasmids carrying the <italic>bla</italic><sub>AFM</sub> gene may continuously acquire additional resistance genes from external sources, driving their evolution. However, the plasmid is relatively large and lacks an oriT site, which may explain its inability to transfer. Moreover, we observed that these <italic>bla</italic><sub>AFM</sub>-positive CRPA strains not only harbor the <italic>bla</italic><sub>AFM</sub> gene but also carry multiple important resistance genes. Notably, over time, the variety of resistance genes carried by <italic>bla</italic><sub>AFM</sub>-positive CRPA strains has steadily increased.</p><p>In studies of human and animal microbiomes, a considerable proportion of plasmids have been found to be untypeable using existing replicon-based classification systems. For instance, a study involving donors from China and the United States identified 5,372 plasmid-like clusters (PLCs), of which only 18.9% (155 clusters) could be assigned to one of the 37 known replicon types; the remaining 81.1% were untypeable (<xref rid="ref27" ref-type="bibr">Yang et al., 2023</xref>). These untypeable plasmids may possess novel replication mechanisms or exhibit highly divergent replication origin sequences. Importantly, they often carry multiple antimicrobial resistance genes and evade detection by current replicon-based surveillance frameworks (<xref rid="ref13" ref-type="bibr">Lassalle et al., 2023</xref>). As a result, conventional plasmid epidemiology may fail to capture their distribution and contribution to resistance dissemination. The prevalence of untypeable plasmids highlights the remarkable genomic plasticity of bacteria and underscores their relevance in tracking resistance spread, improving monitoring strategies, and designing novel genetic vectors.</p><p>Despite the geographic diversity of the <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates, evolutionary analysis revealed only minimal SNP diffe rences between isolates from different regions, indicating a potential risk for the transmission of resistance genes due to population movement. Notably, we observed that the <italic>bla</italic><sub>AFM</sub> gene often coexists with the <italic>bla</italic><sub>KPC</sub> and <italic>tmexCD-toprJ</italic> genes. Previous studies have shown that the <italic>tmexCD-toprJ</italic> efflux pump system can mediate resistance to tigecycline. As tigecycline is considered a last-resort antibiotic for treating infections caused by carbapenem-resistant bacteria, the emergence of <italic>tmexCD-toprJ</italic>-positive carbapenem-resistant strains compromises the efficacy of tigecycline, severely limiting therapeutic options and increasing the risk of clinical treatment failure (<xref rid="ref31" ref-type="bibr">Zhang et al., 2022</xref>; <xref rid="ref9" ref-type="bibr">He et al., 2019</xref>).</p><p>Insertion sequences and plasmids are crucial in mediating the spread of resistance genes (<xref rid="ref16" ref-type="bibr">Li et al., 2024</xref>). To further investigate their roles in <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates, we conducted a correlation analysis. We found that, unlike other carbapenem-resistant bacteria, plasmids play a limited role in the acquisition of foreign resistance genes in <italic>bla</italic><sub>AFM</sub>-positive CRPA (<xref rid="ref17" ref-type="bibr">Li et al., 2024</xref>). The acquisition and spread of resistance genes appear to be primarily associated with insertion sequences, such as IS<italic>Cfr1</italic>, IS<italic>Pre1</italic>, and IS<italic>1491</italic> (<xref rid="ref15" ref-type="bibr">Li et al., 2025</xref>). Additionally, we observed significant positive correlations between the <italic>bla</italic><sub>AFM</sub> gene and multiple other resistance genes, which may result in a multidrug-resistant phenotype. This highlights the potential risk and warrants increased vigilance in managing these strains.</p><p>We acknowledge several limitations in the current study. First, only a single <italic>bla</italic><sub>AFM</sub>-positive CRPA isolate was recovered, limiting the sample size and broader representativeness. Second, our analysis focused solely on <italic>bla</italic><sub>AFM</sub>-positive CRPA strains from China, without including genomic comparisons with globally reported <italic>bla</italic><sub>AFM</sub>-positive CRPA isolates.</p></sec><sec sec-type="conclusions" id="sec18"><title>Conclusion</title><p>This study systematically analyzed the genomic epidemiological characteristics of <italic>bla</italic><sub>AFM</sub>-positive CRPA in China, revealing the resistance gene profiles and evolutionary traits associated with these isolates. <italic>bla</italic><sub>AFM-1</sub> and <italic>bla</italic><sub>AFM-2</sub> were identified as the predominant <italic>bla</italic><sub>AFM</sub> variants, and <italic>bla</italic><sub>AFM</sub>-positive CRPA strains from China were frequently found to harbor multiple critical resistance genes and exhibit diverse ST types. The resistance genes in <italic>bla</italic><sub>AFM</sub>-positive CRPA strains from different regions demonstrated potential for interregional dissemination. The emergence of <italic>bla</italic><sub>AFM</sub>-positive CRPA across multiple provinces in China highlights the urgent need for stringent monitoring and the implementation of appropriate measures to mitigate the future threats posed by these strains.</p></sec></body><back><ack><p>This work was supported by National Supercomputing Center in Zhengzhou.</p></ack><fn-group><fn id="fn0001"><p>
<sup>1</sup>
<ext-link xlink:href="https://github.com/tseemann/snp-dists" ext-link-type="uri">https://github.com/tseemann/snp-dists</ext-link>
</p></fn></fn-group><sec sec-type="data-availability" id="sec19"><title>Data availability statement</title><p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref rid="SM1" ref-type="supplementary-material">Supplementary material</xref>.</p></sec><sec sec-type="ethics-statement" id="sec20"><title>Ethics statement</title><p>The studies involving humans were approved by this study was approved by the Ethics Committee of Zhengzhou University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants&#x02019; legal guardians/next of kin in accordance with the national legislation and institutional requirements.</p></sec><sec sec-type="author-contributions" id="sec21"><title>Author contributions</title><p>HL: Investigation, Writing &#x02013; original draft, Resources. CZ: Methodology, Software, Writing &#x02013; original draft. BZ: Data curation, Formal analysis, Writing &#x02013; original draft. YL: Project administration, Visualization, Writing &#x02013; review &#x00026; editing. SQ: Funding acquisition, Project administration, Resources, Writing &#x02013; review &#x00026; editing.</p></sec><sec sec-type="COI-statement" id="sec23"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="ai-statement" id="sec24"><title>Generative AI statement</title><p>The authors declare that no Gen AI was used in the creation of this manuscript.</p></sec><sec sec-type="disclaimer" id="sec25"><title>Publisher&#x02019;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="sec26"><title>Supplementary material</title><p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2025.1546662/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2025.1546662/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data"><media xlink:href="Table_1.XLSX"/></supplementary-material></sec><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alikhan</surname><given-names>N. F.</given-names></name><name><surname>Petty</surname><given-names>N. K.</given-names></name><name><surname>Ben Zakour</surname><given-names>N. L.</given-names></name><name><surname>Beatson</surname><given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>BLAST ring image generator (BRIG): simple prokaryote genome comparisons</article-title>. <source>BMC Genomics</source>
<volume>12</volume>:<fpage>402</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2164-12-402</pub-id>, PMID: <pub-id pub-id-type="pmid">21824423</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankevich</surname><given-names>A.</given-names></name><name><surname>Nurk</surname><given-names>S.</given-names></name><name><surname>Antipov</surname><given-names>D.</given-names></name><name><surname>Gurevich</surname><given-names>A. A.</given-names></name><name><surname>Dvorkin</surname><given-names>M.</given-names></name><name><surname>Kulikov</surname><given-names>A. S.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing</article-title>. <source>J. Comput. Biol.</source>
<volume>19</volume>, <fpage>455</fpage>&#x02013;<lpage>477</lpage>. doi: <pub-id pub-id-type="doi">10.1089/cmb.2012.0021</pub-id>, PMID: <pub-id pub-id-type="pmid">22506599</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bortolaia</surname><given-names>V.</given-names></name><name><surname>Kaas</surname><given-names>R. S.</given-names></name><name><surname>Ruppe</surname><given-names>E.</given-names></name><name><surname>Roberts</surname><given-names>M. C.</given-names></name><name><surname>Schwarz</surname><given-names>S.</given-names></name><name><surname>Cattoir</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2020</year>). <article-title>ResFinder 4.0 for predictions of phenotypes from genotypes</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>75</volume>, <fpage>3491</fpage>&#x02013;<lpage>3500</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkaa345</pub-id>, PMID: <pub-id pub-id-type="pmid">32780112</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carattoli</surname><given-names>A.</given-names></name><name><surname>Hasman</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>PlasmidFinder and <italic>in silico</italic> pMLST: identification and typing of plasmid replicons in whole-genome sequencing (WGS)</article-title>. <source>Methods Mol. Biol.</source>
<volume>2075</volume>, <fpage>285</fpage>&#x02013;<lpage>294</lpage>. doi: <pub-id pub-id-type="doi">10.1007/978-1-4939-9877-7_20</pub-id>, PMID: <pub-id pub-id-type="pmid">31584170</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Hua</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title>Plasmid-borne AFM alleles in <italic>Pseudomonas aeruginosa</italic> clinical isolates from China</article-title>. <source>Microbiol. Spectr.</source>
<volume>10</volume>:<fpage>e0203522</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.02035-22</pub-id>, PMID: <pub-id pub-id-type="pmid">36000902</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab id="coll1">CLSI</collab></person-group> (<year>2018</year>). <source>Performance standards for antimicrobial susceptibility testing</source>. <edition>28th</edition> Edn. CLSI supplement M100. <publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>An XDR <italic>Pseudomonas aeruginosa</italic> ST463 strain with an IncP-2 plasmid containing a novel transposon Tn<italic>6485f</italic> encoding Bla(IMP-45) and Bla(AFM-1) and a second plasmid with two copies of Bla(KPC-2)</article-title>. <source>Microbiol. Spectr.</source>
<volume>11</volume>:<fpage>e0446222</fpage>. doi: <pub-id pub-id-type="doi">10.1128/spectrum.04462-22</pub-id>, PMID: <pub-id pub-id-type="pmid">36651737</pub-id>
</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>H. K.</given-names></name><name><surname>Beaird</surname><given-names>O. E.</given-names></name><name><surname>Smith</surname><given-names>E. A.</given-names></name><name><surname>Schaenman</surname><given-names>J. M.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>Domestically acquired NDM-1-producing <italic>Pseudomonas aeruginosa</italic>, Southern California, USA, 2023</article-title>. <source>Emerg. Infect. Dis.</source>
<volume>29</volume>, <fpage>2382</fpage>&#x02013;<lpage>2385</lpage>. doi: <pub-id pub-id-type="doi">10.3201/eid2911.230646</pub-id>, PMID: <pub-id pub-id-type="pmid">37877613</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>D. J.</given-names></name><name><surname>Walsh</surname><given-names>T. R.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>1450</fpage>&#x02013;<lpage>1456</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-019-0445-2</pub-id>, PMID: <pub-id pub-id-type="pmid">31133751</pub-id>
</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Zeng</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>Q.</given-names></name><name><surname>Shu</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2021</year>). <article-title>Emergence and expansion of a Carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> clone are associated with plasmid-borne Bla (KPC-2) and virulence-related genes</article-title>. <source>mSystems</source>
<volume>6</volume>:<fpage>6</fpage>. doi: <pub-id pub-id-type="doi">10.1128/mSystems.00154-21</pub-id>, PMID: <pub-id pub-id-type="pmid">34006625</pub-id>
</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jean</surname><given-names>S. S.</given-names></name><name><surname>Gould</surname><given-names>I. M.</given-names></name><name><surname>Lee</surname><given-names>W. S.</given-names></name><name><surname>Hsueh</surname><given-names>P. R.</given-names></name></person-group> (<year>2019</year>). <article-title>International society of antimicrobial C. New drugs for multidrug-resistant gram-negative organisms: time for stewardship</article-title>. <source>Drugs</source>
<volume>79</volume>, <fpage>705</fpage>&#x02013;<lpage>714</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40265-019-01112-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30972660</pub-id>
</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinheinz</surname><given-names>K. A.</given-names></name><name><surname>Joensen</surname><given-names>K. G.</given-names></name><name><surname>Larsen</surname><given-names>M. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Applying the ResFinder and virulence finder web-services for easy identification of acquired antibiotic resistance and <italic>E. coli</italic> virulence genes in bacteriophage and prophage nucleotide sequences</article-title>. <source>Bacteriophage</source>
<volume>4</volume>:<fpage>e27943</fpage>:<fpage>e27943</fpage>. doi: <pub-id pub-id-type="doi">10.4161/bact.27943</pub-id>, PMID: <pub-id pub-id-type="pmid">24575358</pub-id>
</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassalle</surname><given-names>F.</given-names></name><name><surname>Al-Shalali</surname><given-names>S.</given-names></name><name><surname>Al-Hakimi</surname><given-names>M.</given-names></name><name><surname>Njamkepo</surname><given-names>E.</given-names></name><name><surname>Bashir</surname><given-names>I. M.</given-names></name><name><surname>Dorman</surname><given-names>M. J.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Genomic epidemiology reveals multidrug resistant plasmid spread between <italic>Vibrio cholerae</italic> lineages in Yemen</article-title>. <source>Nat. Microbiol.</source>
<volume>8</volume>, <fpage>1787</fpage>&#x02013;<lpage>1798</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41564-023-01472-1</pub-id>, PMID: <pub-id pub-id-type="pmid">37770747</pub-id>
</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letunic</surname><given-names>I.</given-names></name><name><surname>Bork</surname><given-names>P.</given-names></name></person-group> (<year>2021</year>). <article-title>Interactive tree of life (iTOL) v5: an online tool for phylogenetic tree display and annotation</article-title>. <source>Nucleic Acids Res.</source>
<volume>49</volume>, <fpage>W293</fpage>&#x02013;<lpage>W296</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkab301</pub-id>, PMID: <pub-id pub-id-type="pmid">33885785</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Chi</surname><given-names>L.</given-names></name><name><surname>Jin</surname><given-names>C. Y.</given-names></name><etal/></person-group>. (<year>2025</year>). <article-title>The evolution of carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> in the COVID-19 era: a global perspective and regional insights</article-title>. <source>Int. J. Antimicrob. Agents</source>
<volume>65</volume>:<fpage>107466</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2025.107466</pub-id><pub-id pub-id-type="pmid">39971140</pub-id>
</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name></person-group> (<year>2024</year>). <article-title>Global distribution and genomic characteristics of carbapenemase-producing <italic>Escherichia coli</italic> among humans, 2005-2023</article-title>. <source>Drug Resist. Updat.</source>
<volume>72</volume>:<fpage>101031</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.drup.2023.101031</pub-id>, PMID: <pub-id pub-id-type="pmid">38071860</pub-id>
</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Ju</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2024</year>). <article-title>National genomic epidemiology investigation revealed the spread of carbapenem-resistant <italic>Escherichia coli</italic> in healthy populations and the impact on public health</article-title>. <source>Genome Med.</source>
<volume>16</volume>:<fpage>57</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13073-024-01310-x</pub-id>, PMID: <pub-id pub-id-type="pmid">38627827</pub-id>
</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Moran</surname><given-names>R. A.</given-names></name><name><surname>Ke</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title><italic>Alcaligenes faecalis</italic> metallo-beta-lactamase in extensively drug-resistant <italic>Pseudomonas aeruginosa</italic> isolates</article-title>. <source>Clin. Microbiol. Infect.</source>
<volume>28</volume>, <fpage>880.e1</fpage>&#x02013;<lpage>e8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmi.2021.11.012</pub-id>, PMID: <pub-id pub-id-type="pmid">34826621</pub-id>
</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livermore</surname><given-names>D. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple mechanisms of antimicrobial resistance in <italic>Pseudomonas aeruginosa</italic>: our worst nightmare?</article-title>
<source>Clin. Infect. Dis.</source>
<volume>34</volume>, <fpage>634</fpage>&#x02013;<lpage>640</lpage>. doi: <pub-id pub-id-type="doi">10.1086/338782</pub-id>, PMID: <pub-id pub-id-type="pmid">11823954</pub-id>
</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchaim</surname><given-names>D.</given-names></name><name><surname>Pogue</surname><given-names>J. M.</given-names></name><name><surname>Tzuman</surname><given-names>O.</given-names></name><name><surname>Hayakawa</surname><given-names>K.</given-names></name><name><surname>Lephart</surname><given-names>P. R.</given-names></name><name><surname>Salimnia</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Major variation in MICs of tigecycline in gram-negative bacilli as a function of testing method</article-title>. <source>J. Clin. Microbiol.</source>
<volume>52</volume>, <fpage>1617</fpage>&#x02013;<lpage>1621</lpage>. doi: <pub-id pub-id-type="doi">10.1128/JCM.00001-14</pub-id>, PMID: <pub-id pub-id-type="pmid">24599978</pub-id>
</mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>M. N.</given-names></name><name><surname>Dehal</surname><given-names>P. S.</given-names></name><name><surname>Arkin</surname><given-names>A. P.</given-names></name></person-group> (<year>2009</year>). <article-title>FastTree: computing large minimum evolution trees with profiles instead of a distance matrix</article-title>. <source>Mol. Biol. Evol.</source>
<volume>26</volume>, <fpage>1641</fpage>&#x02013;<lpage>1650</lpage>. doi: <pub-id pub-id-type="doi">10.1093/molbev/msp077</pub-id>, PMID: <pub-id pub-id-type="pmid">19377059</pub-id>
</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>J.</given-names></name><name><surname>Komarow</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Ge</surname><given-names>L.</given-names></name><name><surname>Hanson</surname><given-names>B. M.</given-names></name><name><surname>Cober</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Global epidemiology and clinical outcomes of carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> and associated carbapenemases (POP): a prospective cohort study</article-title>. <source>Lancet Microbe</source>
<volume>4</volume>, <fpage>e159</fpage>&#x02013;<lpage>e170</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2666-5247(22)00329-9</pub-id>, PMID: <pub-id pub-id-type="pmid">36774938</pub-id>
</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saravanan</surname><given-names>M.</given-names></name><name><surname>Belete</surname><given-names>M. A.</given-names></name><name><surname>Arockiaraj</surname><given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> in intensive care units increase mortality as an emerging global threat</article-title>. <source>Int. J. Surg.</source>
<volume>109</volume>, <fpage>1034</fpage>&#x02013;<lpage>1036</lpage>. doi: <pub-id pub-id-type="doi">10.1097/JS9.0000000000000184</pub-id>, PMID: <pub-id pub-id-type="pmid">36999801</pub-id>
</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Prokka: rapid prokaryotic genome annotation</article-title>. <source>Bioinformatics</source>
<volume>30</volume>, <fpage>2068</fpage>&#x02013;<lpage>2069</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id>, PMID: <pub-id pub-id-type="pmid">24642063</pub-id>
</mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>M. J.</given-names></name><name><surname>Petty</surname><given-names>N. K.</given-names></name><name><surname>Beatson</surname><given-names>S. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Easyfig: a genome comparison visualizer</article-title>. <source>Bioinformatics</source>
<volume>27</volume>, <fpage>1009</fpage>&#x02013;<lpage>1010</lpage>. doi: <pub-id pub-id-type="doi">10.1093/bioinformatics/btr039</pub-id>, PMID: <pub-id pub-id-type="pmid">21278367</pub-id>
</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wick</surname><given-names>R. R.</given-names></name><name><surname>Judd</surname><given-names>L. M.</given-names></name><name><surname>Gorrie</surname><given-names>C. L.</given-names></name><name><surname>Holt</surname><given-names>K. E.</given-names></name></person-group> (<year>2017</year>). <article-title>Unicycler: resolving bacterial genome assemblies from short and long sequencing reads</article-title>. <source>PLoS Comput. Biol.</source>
<volume>13</volume>:<fpage>e1005595</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pcbi.1005595</pub-id>, PMID: <pub-id pub-id-type="pmid">28594827</pub-id>
</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Mai</surname><given-names>G.</given-names></name><name><surname>Hu</surname><given-names>Z.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Dai</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Global transmission of broad-host-range plasmids derived from the human gut microbiome</article-title>. <source>Nucleic Acids Res.</source>
<volume>51</volume>, <fpage>8005</fpage>&#x02013;<lpage>8019</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gkad498</pub-id>, PMID: <pub-id pub-id-type="pmid">37283060</pub-id>
</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>E. J.</given-names></name><name><surname>Jeong</surname><given-names>S. H.</given-names></name></person-group> (<year>2021</year>). <article-title>Mobile Carbapenemase Genes in <italic>Pseudomonas aeruginosa</italic></article-title>. <source>Front. Microbiol.</source>
<volume>12</volume>:<fpage>614058</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2021.614058</pub-id>, PMID: <pub-id pub-id-type="pmid">33679638</pub-id>
</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Qian</surname><given-names>C.</given-names></name><name><surname>Zheng</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Characteristics of rare ST463 carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> clinical isolates from blood</article-title>. <source>J. Glob. Antimicrob. Resist.</source>
<volume>32</volume>, <fpage>122</fpage>&#x02013;<lpage>130</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2023.01.011</pub-id>, PMID: <pub-id pub-id-type="pmid">36801256</pub-id>
</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Guo</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name></person-group> (<year>2021</year>). <article-title>Characterization of the novel plasmid-encoded MBL gene <italic>bla</italic><sub>AFM-1</sub>, integrated into a <italic>bla</italic><sub>IMP-45</sub>-bearing transposon Tn<italic>6485e</italic> in a carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> clinical isolate</article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>77</volume>, <fpage>83</fpage>&#x02013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1093/jac/dkab342</pub-id>, PMID: <pub-id pub-id-type="pmid">34545931</pub-id>
</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2022</year>). <article-title><italic>In vivo</italic> acquisition of Bla(KPC-2) with low biological cost in Bla(AFM-1)-harboring ST463 hypervirulent <italic>Pseudomonas aeruginosa</italic> from a patient with hematologic malignancy</article-title>. <source>J. Glob. Antimicrob. Resist.</source>
<volume>31</volume>, <fpage>189</fpage>&#x02013;<lpage>195</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2022.09.004</pub-id>, PMID: <pub-id pub-id-type="pmid">36182079</pub-id>
</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title><italic>Pseudomonas aeruginosa</italic> high-risk sequence type 463 co-producing KPC-2 and AFM-1 Carbapenemases, China, 2020-2022</article-title>. <source>Emerg. Infect. Dis.</source>
<volume>29</volume>, <fpage>2136</fpage>&#x02013;<lpage>2140</lpage>. doi: <pub-id pub-id-type="doi">10.3201/eid2910.230509</pub-id>, PMID: <pub-id pub-id-type="pmid">37735755</pub-id>
</mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Tu</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2023</year>). <article-title>Characterization of a novel Tn<italic>6485h</italic> transposon carrying both <italic>bla</italic><sub>IMP-45</sub> and <italic>bla</italic><sub>AFM-1</sub> integrated into the IncP-2 plasmid in a carbapenem-resistant <italic>Pseudomonas aeruginosa</italic></article-title>. <source>J. Glob. Antimicrob. Resist.</source>
<volume>35</volume>, <fpage>307</fpage>&#x02013;<lpage>313</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jgar.2023.10.010</pub-id>, PMID: <pub-id pub-id-type="pmid">37879457</pub-id>
</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>P.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Chu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name></person-group> (<year>2023</year>). <article-title>The epidemiology and virulence of carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> in China</article-title>. <source>Lancet Microbe</source>
<volume>4</volume>:<fpage>e665</fpage>. doi: <pub-id pub-id-type="doi">10.1016/S2666-5247(23)00113-1</pub-id>, PMID: <pub-id pub-id-type="pmid">37327803</pub-id>
</mixed-citation></ref></ref-list></back></article>